SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for QUANTA INC (CIK 0001691430) — Sep 8, 2020

QUANTA INC (CIK 0001691430)
Date: Sept. 8, 2020 · CIK: 0001691430 · Accession: 0000000000-20-008413

AI Filing Summary & Sentiment

File numbers found in text: 333-248553

Date
September 8, 2020
Author
Not clearly detected
Form
UPLOAD
Company
QUANTA INC (CIK 0001691430)

Letter

United States securities and exchange commission logo September 8, 2020 Eric Rice Chief Executive Officer Quanta, Inc. 3606 W. Magnolia Blvd Burbank, CA 91505 Re:Quanta, Inc. Registration Statement on Form S-1 Filed September 2, 2020 File No. 333-248553 Dear Mr. Rice: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jason L. Drory at 202-551-8342 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matheau J. W. Stout, Esq.

Show Raw Text
United States securities and exchange commission logo
September 8, 2020
Eric Rice
Chief Executive Officer
Quanta, Inc.
3606 W. Magnolia Blvd
Burbank, CA 91505
Re:Quanta, Inc.
Registration Statement on Form S-1
Filed September 2, 2020
File No. 333-248553
Dear Mr. Rice:
            This is to advise you that we have not reviewed and will not review your registration
statement.
            Please refer to Rules 460 and 461 regarding requests for acceleration.  We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
            Please contact Jason L. Drory at 202-551-8342 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc:       Matheau J. W. Stout, Esq.